Pharmaceuticals News

WALTHAM, Mass., April 24, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the...

World’s first Phase 3 readout for an in vivo CRISPR gene editing candidateCompany to host webcast to discuss data at 8:00 a.m. ET on April 27, 2026 CAMBRIDGE, Mass., April 24, 2026 (GLOBE NEWSWIRE)...

- Annual Shareholder Meeting to be held at 10:00 am PT on June 17, 2026 - IRVINE, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a...

Ruling preserves current contracted royalty rates and rejects Tesaro’s request for any royalty reductionTrial to adjudicate Anaptys’ contract claims and right to seek reversion of Jemperli against...

NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Plopii, a Brooklyn-based biotechnology company specializing in consumer wellness products and drug patent development centered on paraxanthine,...

Sanofi place 2,3 milliard d’euros d’emprunts obligataires  Paris, 24 avril 2026 - Sanofi annonce avoir placé avec succès une émission obligataire en 3 tranches (les « obligations ») pour un montant...

Sanofi successfully prices 2.3 billion of bond issue   Paris, April 24, 2026 - Sanofi announces that it has successfully priced its offering of €2.3 billion of notes across 3 tranches:  €1,000...

Goedkeuring van het dividendGereglementeerde informatie - 24 april 2026 De algemene vergadering van aandeelhouders van 24 april 2026 heeft de jaarrekening afgesloten op 31 december 2025, met inbegrip...

Approbation du dividendeInformation réglementée - 24 avril 2026 L’assemblée générale des actionnaires du 24 avril 2026 a approuvé les comptes annuels relatifs à l’exercice social clôturé le 31...

Dividend confirmationRegulated information - 24 April 2026 The general shareholders meeting of 24 April 2026 has approved the annual accounts as at 31 December 2025, including the distribution of a...